US Patent 7205327 Imidazole and benzimidazole caspase inhibitors and uses thereof
Patent 7205327 was granted and assigned to Vertex Pharmaceuticals on April, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
David Kay0
Julian M. C. Golec0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+77 characters)
Article
Patent abstract
This invention provides caspase inhibitors having the formula:
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07205327 Imidazole and benzimidazole caspase inhibitors and uses thereof US Patent 7205327 Imidazole and benzimidazole caspase inhibitors and uses thereof
Infobox
Patent Number
072053270
Patent Number
72053270
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072053270
Date of Patent
April 17, 2007
0Patent Application Number
100127220
Date Filed
November 19, 2001
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07205327 Imidazole and benzimidazole caspase inhibitors and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07205327
Date of patent
April 17, 2007
Patent application number
10012722
Date Filed
November 19, 2001
Patent primary examiner
Find more entities like US Patent 7205327 Imidazole and benzimidazole caspase inhibitors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
